WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MIRM

Based on 7 analysts offering 12 month price targets for Mirum Pharmaceuticals Inc.
Min Forecast
$37.00+15.63%
Avg Forecast
$59.43+85.72%
Max Forecast
$77.00+140.63%

Should I buy or sell MIRM stock?

Based on 7 analysts offering ratings for Mirum Pharmaceuticals Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
3 analysts 42.86%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MIRM stock forecasts and price targets.

MIRM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-27
lockedlocked$00.00+00.00%2023-11-20
lockedlocked$00.00+00.00%2023-11-13
lockedlocked$00.00+00.00%2023-11-03
lockedlocked$00.00+00.00%2023-10-18
Raymond James
Bottom 25%
25
Strong BuyMaintains$77.00+140.63%2023-10-18
Evercore ISI Group
Bottom 12%
12
BuyReinstates$62.00+93.75%2023-10-17

1 of 1

Forecast return on equity

Is MIRM forecast to generate an efficient return?
Company
N/A
Industry
-0.7%
Market
30.07%

Forecast return on assets

Is MIRM forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.21%

MIRM revenue forecast

What is MIRM's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$184.8M+27.68%
Avg 2 year Forecast
$326.9M+125.89%
Avg 3 year Forecast
$446.4M+208.47%
MIRM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MIRM revenue growth forecast

How is MIRM forecast to perform vs Biotechnology companies and vs the US market?
Company
45.98%
Industry
34.35%
Market
7.5%
MIRM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MIRM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MIRM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MIRM$32.00$59.43+85.72%Strong Buy
SMMT$2.13N/AN/A
PNT$13.80$13.00-5.80%Buy
CLDX$32.02$53.00+65.52%Buy
MRUS$25.13$43.43+72.82%Strong Buy
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Forecast FAQ

Is Mirum Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: MIRM) stock is to Strong Buy MIRM stock.

Out of 7 analysts, 4 (57.14%) are recommending MIRM as a Strong Buy, 3 (42.86%) are recommending MIRM as a Buy, 0 (0%) are recommending MIRM as a Hold, 0 (0%) are recommending MIRM as a Sell, and 0 (0%) are recommending MIRM as a Strong Sell.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.

What is MIRM's revenue growth forecast for 2023-2025?

(NASDAQ: MIRM) Mirum Pharmaceuticals's forecast annual revenue growth rate of 45.98% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.35%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.5%.

Mirum Pharmaceuticals's revenue in 2023 is $144,726,000.On average, 5 Wall Street analysts forecast MIRM's revenue for 2023 to be $8,613,432,164, with the lowest MIRM revenue forecast at $8,567,050,961, and the highest MIRM revenue forecast at $8,642,286,400. On average, 5 Wall Street analysts forecast MIRM's revenue for 2024 to be $15,238,998,613, with the lowest MIRM revenue forecast at $14,398,683,096, and the highest MIRM revenue forecast at $16,366,271,601.

In 2025, MIRM is forecast to generate $20,810,429,870 in revenue, with the lowest revenue forecast at $18,588,840,186 and the highest revenue forecast at $23,419,477,400.

What is MIRM's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MIRM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.21%.

What is MIRM's Price Target?

According to 7 Wall Street analysts that have issued a 1 year MIRM price target, the average MIRM price target is $59.43, with the highest MIRM stock price forecast at $77.00 and the lowest MIRM stock price forecast at $37.00.

On average, Wall Street analysts predict that Mirum Pharmaceuticals's share price could reach $59.43 by Nov 27, 2024. The average Mirum Pharmaceuticals stock price prediction forecasts a potential upside of 85.72% from the current MIRM share price of $32.00.

What is MIRM's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MIRM) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.